Practical Geriatrics ›› 2026, Vol. 40 ›› Issue (10): 1012-1017.doi: 10.3969/j.issn.1003-9198.2026.10.007

Previous Articles     Next Articles

Development and validation of a risk prediction model for venous thromboembolism in elderly patients with lung cancer

CHEN Lingli, BAI Zhaoshi, WEI Qiang   

  1. Department of Critical Care Medicine(CHEN Lingli); Department of Pharmacy(BAI Zhaoshi); Department of Ultrasound Medicine(WEI Qiang), Jiangsu Cancer Hospital/Jiangsu Institute of Cancer Research/The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2026-04-23 Published:2026-10-23
  • Contact: WEI Qiang, Email:13770630278@163.com

Abstract: Objective To analyze the risk factors for venous thromboembolism(VTE) in elderly patients with lung cancer, and to construct and validate a nomogram prediction model. Methods A total of 300 elderly patients with lung cancer admitted to Jiangsu Cancer Hospital from January 2020 to December 2024 were retrospectively collected as the modeling cohort. The cohort was randomly divided into a training set and an internal validation set at a 7∶3 ratio. In addition, 90 elderly patients with lung cancer treated from January to December 2025 were selected as the temporal validation set. According to the occurrence of VTE, patients in the modeling cohort were divided into a VTE group(n=128) and a non-VTE group(n=172). Multivariate logistic regression analysis was used to identify the independent risk factors for VTE in elderly patients with lung cancer, and a nomogram was constructed. Model performance was assessed using receiver operating characteristic(ROC) curves, calibration curves, and decision curve analysis(DCA). Results Multivariate logistic regression analysis showed that clinical stage Ⅲ-Ⅳ, elevated D-dimer(D-D) and fibrinogen(FIB) levels, prior chemotherapy, central venous catheterization(CVC), and prolonged bed rest were independent risk factors for VTE in elderly patients with lung cancer. The nomogram was established and demonstrated good discrimination, calibration, and net clinical benefit in internal validation. The area under the ROC curve was 0.905(95%CI: 0.841-0.970) in the temporal set indicating stable discriminative ability across time. Conclusions The nomogram constructed in this study demonstrated robust predictive performance and clinical utility which can support risk-stratified management and individualized intervention for VTE in elderly patients with lung cancer.
   

Key words: venous thromboembolism, aged, lung cancer, prediction model, nomogram

CLC Number: